These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34585166

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A.
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [Abstract] [Full Text] [Related]

  • 4. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
    Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, Sidis Y, Schneyer A.
    Obesity (Silver Spring); 2011 Oct; 19(10):1940-9. PubMed ID: 21546932
    [Abstract] [Full Text] [Related]

  • 5. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults.
    Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL.
    Proc Natl Acad Sci U S A; 2007 Jan 23; 104(4):1348-53. PubMed ID: 17229845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FSTL3-Neutralizing Antibodies Enhance Glucose-Responsive Insulin Secretion in Dysfunctional Male Mouse and Human Islets.
    Brown ML, Lopez A, Meyer N, Richter A, Thompson TB.
    Endocrinology; 2021 Oct 01; 162(10):. PubMed ID: 33539535
    [Abstract] [Full Text] [Related]

  • 10. Structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding.
    Cash JN, Angerman EB, Kattamuri C, Nolan K, Zhao H, Sidis Y, Keutmann HT, Thompson TB.
    J Biol Chem; 2012 Jan 06; 287(2):1043-53. PubMed ID: 22052913
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC, Walker RG, Murray NH, Thompson TB.
    J Biol Chem; 2019 Apr 19; 294(16):6333-6343. PubMed ID: 30814254
    [Abstract] [Full Text] [Related]

  • 12. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3.
    Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A.
    Endocrinology; 2005 Dec 19; 146(12):5052-62. PubMed ID: 16150905
    [Abstract] [Full Text] [Related]

  • 13. Follistatin-like 3 (FSTL3) mediated silencing of transforming growth factor β (TGFβ) signaling is essential for testicular aging and regulating testis size.
    Oldknow KJ, Seebacher J, Goswami T, Villen J, Pitsillides AA, O'Shaughnessy PJ, Gygi SP, Schneyer AL, Mukherjee A.
    Endocrinology; 2013 Mar 19; 154(3):1310-20. PubMed ID: 23407452
    [Abstract] [Full Text] [Related]

  • 14. Heparin and activin-binding determinants in follistatin and FSTL3.
    Sidis Y, Schneyer AL, Keutmann HT.
    Endocrinology; 2005 Jan 19; 146(1):130-6. PubMed ID: 15471966
    [Abstract] [Full Text] [Related]

  • 15. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
    Tsuchida K.
    Acta Myol; 2008 Jul 19; 27(1):14-8. PubMed ID: 19108572
    [Abstract] [Full Text] [Related]

  • 16. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.
    Guo J, Tian T, Lu D, Xia G, Wang H, Dong M.
    J Obstet Gynaecol Res; 2012 Jul 19; 38(7):988-96. PubMed ID: 22568578
    [Abstract] [Full Text] [Related]

  • 17. The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity.
    Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A, Thompson TB.
    J Biol Chem; 2008 Nov 21; 283(47):32831-8. PubMed ID: 18768470
    [Abstract] [Full Text] [Related]

  • 18. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
    Brandt C, Hansen RH, Hansen JB, Olsen CH, Galle P, Mandrup-Poulsen T, Gehl J, Pedersen BK, Hojman P.
    Metabolism; 2015 Feb 21; 64(2):283-95. PubMed ID: 25456456
    [Abstract] [Full Text] [Related]

  • 19. Differential actions of follistatin and follistatin-like 3.
    Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, Keutmann H.
    Mol Cell Endocrinol; 2004 Oct 15; 225(1-2):25-8. PubMed ID: 15451564
    [Abstract] [Full Text] [Related]

  • 20. Synexpression group analyses identify new functions of FSTL3, a TGFβ ligand inhibitor.
    Robertson RD, Mukherjee A.
    Biochem Biophys Res Commun; 2012 Oct 26; 427(3):568-73. PubMed ID: 23022195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.